z-logo
open-access-imgOpen Access
Experience with second-line trabectedin in daily clinical practice: case studies
Author(s) -
Javier MartínBroto,
Nadia Hindi,
Giovanni Grignani,
Alessandra Merlini,
Tony Ibrahim,
Axel Le Cesne
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0519
Subject(s) - trabectedin , medicine , tolerability , liposarcoma , soft tissue sarcoma , adverse effect , asymptomatic , oncology , leiomyosarcoma , first line , myxoid liposarcoma , sarcoma , surgery , soft tissue , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom